FRI0397 EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL: RESULTS FROM THE 48-WEEK RUN-IN PART OF C-OPTIMISE.

2019

https://researcherprofiles.org/profile/79293228

Robert B.M. Landewé, Désirée van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip van den Bosch, Karl Gaffney, Natasha de Peyrecave, Lars Bauer, Bengt Hoepken, Karen Thomas, Lianne S. Gensler

Center for Advancing Scholarship in Education

Center for Faculty Educators

FRI0397 EFFICACY AND SAFETY OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL: RESULTS FROM THE 48-WEEK RUN-IN PART OF C-OPTIMISE.